You have 9 free searches left this month | for more free features.

Confidence Intervals

Showing 1 - 25 of 8,364

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

COVID-19 Novel Molecular Point of Care Diagnostics Evaluation

Completed
  • COVID-19 Respiratory Infection
    • Geneva, Switzerland
    • +2 more
    Sep 25, 2023

    Heart Failure Trial in Ibadan

    Recruiting
    • Heart Failure
      • Ibadan, Oyo, Nigeria
        University College Hospital Ibadan
      Jun 29, 2023

      Urdu Version of Tinetti Falls Efficacy Scale

      Completed
      • Stroke
        • Lahore, Punjab, Pakistan
          University of Lahore Teaching Hospital
        Sep 12, 2023

        Inpatient COVID-19 Treatments

        Active, not recruiting
        • COVID-19
        • Initiation of IL6Ri (tocilizumab or sarilumab) versus JAKi (baricitinib or tofacitinib) added to systemic corticosteroids of interest (CSI)
        • New York, New York
          Aetion, Inc.
        Jan 12, 2023

        Next Generation LAM Assays and Molecular Diagnostics for

        Not yet recruiting
        • Tuberculosis
          • (no location specified)
          Aug 24, 2023

          Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma, Pathologic Stage IIIC Cutaneous Melanoma AJCC v8 Trial in

          Not yet recruiting
          • Clinical Stage IV Cutaneous Melanoma AJCC v8
          • +3 more
          • Biospecimen Collection
          • +8 more
          • Kansas City, Kansas
            University of Kansas Cancer Center
          Nov 27, 2023

          Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in Seattle

          Not yet recruiting
          • Metastatic Lung Non-Small Cell Carcinoma
          • +2 more
          • Atezolizumab
          • +6 more
          • Seattle, Washington
            Fred Hutch/University of Washington Cancer Consortium
          Jul 6, 2023

          Novel Thermal Imaging Technique for Breast Screening

          Recruiting
          • Breast Cancer
          • Thermalytix
          • Tucson, Arizona
            University of Arizona Cancer Center
          Dec 14, 2022

          Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Estrogen Receptor-Positive Breast Carcinoma

          Not yet recruiting
          • Anatomic Stage 0 Breast Cancer AJCC v8
          • +3 more
          • Accelerated Partial Breast Irradiation
          • Duarte, California
            City of Hope Medical Center
          Aug 18, 2023

          Lung Non-Small Cell Carcinoma Trial (Amivantamab, Biospecimen Collection, Computed Tomography)

          Not yet recruiting
          • Lung Non-Small Cell Carcinoma
          • Amivantamab
          • +3 more
          • (no location specified)
          Oct 30, 2023

          Non-Alcoholic Fatty Liver Disease Trial in Seoul (GODEX, Placebo)

          Enrolling by invitation
          • Non-Alcoholic Fatty Liver Disease
          • Seoul, Korea, Republic of
            Seoul National University Hospital
          Nov 30, 2023

          Educational Activities Trial in Montreal (Intervention)

          Recruiting
          • Educational Activities
          • Intervention
          • Montreal, Quebec, Canada
            Institut de Recherches Cliniques de Montréal
          Sep 2, 2022

          Recurrent Glioblastoma, IDH-Wildtype, Recurrent WHO Grade 2 Glioma, Recurrent WHO Grade 3 Glioma Trial (Biospecimen Collection,

          Not yet recruiting
          • Recurrent Glioblastoma, IDH-Wildtype
          • +2 more
          • Biospecimen Collection
          • +2 more
          • (no location specified)
          May 13, 2023

          Minimal Residual Disease Using Multi-omics Approach

          Not yet recruiting
          • Pancreatic Ductal Adenocarcinoma
          • Blood collection and Pancreatic ductal adenocarcinoma minimal residual disease detection test
          • Shanghai, China
            Department of Pancreatic and Hepatobiliary Surgery, Fudan Univer
          Nov 29, 2023

          Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial in Philadelphia (Magnetic Resonance Imaging, Computed

          Not yet recruiting
          • Hematopoietic and Lymphoid Cell Neoplasm
          • Malignant Solid Neoplasm
          • Magnetic Resonance Imaging
          • +4 more
          • Philadelphia, Pennsylvania
            Sidney Kimmel Cancer Center at Thomas Jefferson University
          Jan 20, 2023

          Cancer, Immune-related Adverse Event, Cardiac Abnormalities, Variable Trial in Belgium (Cardiology consultation, Chest Computed

          Recruiting
          • Cancer
          • +6 more
          • Cardiology consultation
          • +4 more
          • Deinze, East-Flanders, Belgium
          • +3 more
          Jan 26, 2023

          Nasal Polyps, Asthma, COPD Trial in Oulu (Sensor analyzing software (own development), Body plethysmograph)

          Recruiting
          • Nasal Polyps
          • +3 more
          • Sensor analyzing software (own development)
          • Body plethysmograph
          • Oulu, Finland
            Oulu University Hospital
          May 23, 2023

          Meningeal Tumors, Leptomeningeal Disease Trial in Tübingen (No intervention)

          Not yet recruiting
          • Meningeal Neoplasms
          • Leptomeningeal Disease
          • No intervention
          • Tübingen, Germany
            University Hospital Tübingen, Neurooncology
          Nov 16, 2023

          ADHD Trial (DBT for ADHD)

          Not yet recruiting
          • ADHD
          • DBT for ADHD
          • (no location specified)
          Apr 21, 2023

          Epithelial Ovarian Cancer, Anemia, Iron Deficiency Anemia Trial in Madison (Iron Sucrose)

          Terminated
          • Epithelial Ovarian Cancer
          • +2 more
          • Iron Sucrose
          • Madison, Wisconsin
            University of Wisconsin Carbone Cancer Center
          Jan 3, 2023

          Nervous System Tumor Trial (Administration of Indocyanine Green (ICG) and Visualization of Tumor)

          Not yet recruiting
          • Nervous System Tumor
          • Administration of Indocyanine Green (ICG) and Visualization of Tumor
          • (no location specified)
          Feb 17, 2023

          Autoimmune Disorders Trial in United States (Daratumumab)

          Not yet recruiting
          • Autoimmune Disorders
          • Daratumumab
          • Baltimore, Maryland
          • +7 more
          Jan 4, 2023

          Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial (procedure, biological, drug)

          Not yet recruiting
          • Recurrent Lung Non-Small Cell Carcinoma
          • Stage IV Lung Cancer AJCC v8
          • Biospecimen Collection
          • +5 more
          • (no location specified)
          Sep 7, 2023

          Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Baltimore, Buffalo (Gemtuzumab Ozogamicin,

          Recruiting
          • Recurrent Acute Myeloid Leukemia
          • Refractory Acute Myeloid Leukemia
          • Gemtuzumab Ozogamicin
          • +4 more
          • Baltimore, Maryland
          • +1 more
          Dec 13, 2022

          B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, Lymphoblastic Lymphoma Trial

          Not yet recruiting
          • B Acute Lymphoblastic Leukemia
          • +5 more
          • Biospecimen Collection
          • +4 more
          • (no location specified)
          Oct 28, 2022